Metraipolis › archive › dc_4f809408ae36

Cell- and biological-based drug delivery vectors for cancer treatment — Europe PMC PMID:42626194

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42626194
DOI
10.3389/fmolb.2026.1894677
License (as archived)
solo-consultazione
Archived
2026-10-17T00:21:27.924Z
SHA-256 of the archived text
4c8d1660eb55f4300d12ba26c9c404530e72279bdb4db68811626ca5375b5373
Stable URL of this page
https://metraipolis.com/documento/dc_4f809408ae36

How to cite

Cell- and biological-based drug delivery vectors for cancer treatment — Europe PMC PMID:42626194 — Europe PMC (en), https://europepmc.org/article/MED/42626194 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4f809408ae36 (Metraipolis archive dc_4f809408ae36, sha256 4c8d1660eb55f4300d12ba26c9c404530e72279bdb4db68811626ca5375b5373)
BibTeX
@misc{dc4f809408ae36,
  title = {Cell- and biological-based drug delivery vectors for cancer treatment — Europe PMC PMID:42626194},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42626194},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4f809408ae36; sha256 4c8d1660eb55f4300d12ba26c9c404530e72279bdb4db68811626ca5375b5373},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42626194. Agents can read the archived copy with the MCP tool read_document.